Gurman says his anonymous sources with insider knowledge of Apple tell him a visual plan “currently being tested” is a ...

Eli Lilly is leading the GLP-1 charge, but investors have already priced much of the good news into the stock.

By Sriparna Roy April 17 (Reuters) - Eli Lilly's newly launched weight-loss pill was prescribed 1,390 times in the U.S. in ...

A medical oncologist called the late-stage clinical trial results “remarkable,” though Sasse said the drug means his body ...

At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be ...

Merck & Co.'s Keytruda in the U.S. starts at $12,000 for a 200 mg dose. Costs go up from there based on the insurer, provider ...

For all the death and darkness the Pitt crew had to swallow this season, the finale also offered profound moments of hope and ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

The process of discovering new drugs and bringing them to market is notoriously slow and inefficient. Amazon Web Services is ...

Eli Lilly has announced the availability of the new GLP-1 pill, Foundayo, through Amazon One Medical kiosks starting at $149 ...

By Sriparna Roy and Sahil Pandey April 16 (Reuters) - Eli Lilly said on Thursday its newly approved obesity pill was not ...

Popular weight loss drugs reached a new era this year when they became available in the form of a pill. Now U.S. consumers ...